BioSpace News Archive

PMI Biopharma Solutions a provider of research, pharmaceutical development, and early-phase clinical manufacturing services and Nashville Biosciences, a clinical-genomic and bioinformatics company, today announced a strategic collaboration to leverage both parties’ unique strengths to provide their customers with an integrated product offering around drug discovery and development.

Today, global healthcare solutions leader AmerisourceBergen announced that it is continuing its strategic relationship with the American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings. AmerisourceBergen will support AON in its effort to accelerate key strategic priorities to scale its integrated value-based care delivery model nationwide.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SZSE: 002399), a China-based global pharmaceutical company targeting high-mortality diseases with significant unmet medical needs, announced the appointment of Mr. Frank Sun as Executive Director and the election of Mr. Sun as the Vice Chairman of the Board

Diaceutics announces a series of forecasts based on research published in its annual Pharma Precision Medicine Readiness Report

In partnership with SpaceCells USA Inc. and BioServe Space Technologies, samples are scheduled for launch aboard the SpaceX CRS-20 cargo flight today

The National Academy of Sciences ( NAS ) just released an assessment of a draft report on fluoride neurotoxicity produced by the National Toxicology Program ( NTP ). The NAS suggested improvements to strengthen the report and heavily criticized NTP for ignoring evidence from animal studies and for inadequately addressing the human evidence of fluoride levels

Procter & Gamble requests that their press release NewsItemId: 20200302005123 (issued March 2, 2020) “Herbal Essences Announces Commitment to Help Mitigate Biodiversity Loss” be killed.

New data from a clinical trial of Alzheimer’s Disease using a drug called Nilvadipine identified by researchers at the Roskamp Institute show that patients with very mild (very early stage) Alzheimer’s disease show less cognitive decline over an 18-month period than placebo-treated patients. On the key clinical measure of memory, the

Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment choices for people with cardiorenal diseases, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2019 .

Zosano Pharma Corporation (Nasdaq:ZSAN) (“Zosano”), a clinical-stage biopharmaceutical company, today announced that it has closed its previously-announced registered direct offering priced at-the-market under Nasdaq rules of 11,903,506 shares of its common stock and warrants to purchase up to 11,903,506 shares of its common stock, at a combined purchase price of $0.9275 per share